Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Loss of epigenetic silencing of the DUX4 transcription factor gene in facioscapulohumeral muscular dystrophy.

Human molecular genetics·2015
Same author

A new monoclonal antibody DAG-6F4 against human alpha-dystroglycan reveals reduced core protein in some, but not all, dystroglycanopathy patients.

Neuromuscular disorders : NMD·2014
Same author

Formation of the embryonic organizer is restricted by the competitive influences of Fgf signaling and the SoxB1 transcription factors.

PloS one·2013
Same author

Re-evaluation of the role of calcium homeostasis endoplasmic reticulum protein (CHERP) in cellular calcium signaling.

The Journal of biological chemistry·2012
Same author

Evolution of DUX gene macrosatellites in placental mammals.

Chromosoma·2012
Same author

Defects in glycosylation impair satellite stem cell function and niche composition in the muscles of the dystrophic Large(myd) mouse.

Stem cells (Dayton, Ohio)·2012
Same journal

TDP-43 proteinopathy as a biomarker and therapeutic target in amyotrophic lateral sclerosis.

Biochemical Society transactions·2026
Same journal

Advancing the monitoring of organelle contact sites in vitro and in vivo.

Biochemical Society transactions·2026
Same journal

Mechanisms influencing transient cytoplasmic protein targeting to intracellular lipid droplets.

Biochemical Society transactions·2026
Same journal

Replication associated nuclear DNA mismatch repair across kingdoms.

Biochemical Society transactions·2026
Same journal

Phosphatases of regenerating liver downregulate PTEN to promote tumorigenesis.

Biochemical Society transactions·2026
Same journal

Implications of Rho GTPase signaling in cancer immunotherapy.

Biochemical Society transactions·2026
See all related articles

Related Experiment Video

Updated: Jun 5, 2026

Immunolabelling Myofiber Degeneration in Muscle Biopsies
06:37

Immunolabelling Myofiber Degeneration in Muscle Biopsies

Published on: December 5, 2019

Glycomarkers for muscular dystrophy.

Jane E Hewitt1

  • 1Centre for Genetics and Genomics, School of Biology, Queen's Medical Centre, University of Nottingham, Nottingham NG7 2UH, UK. jane.hewitt@nottingham.ac.uk

Biochemical Society Transactions
|January 27, 2011
PubMed
Summary
This summary is machine-generated.

Errors in alpha-dystroglycan glycosylation cause inherited muscular dystrophies and central nervous system issues. Identifying more genes involved in this O-mannosyl glycan pathway is crucial for understanding these conditions.

More Related Videos

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
09:18

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy

Published on: January 12, 2019

Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases
06:52

Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases

Published on: September 29, 2014

Related Experiment Videos

Last Updated: Jun 5, 2026

Immunolabelling Myofiber Degeneration in Muscle Biopsies
06:37

Immunolabelling Myofiber Degeneration in Muscle Biopsies

Published on: December 5, 2019

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
09:18

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy

Published on: January 12, 2019

Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases
06:52

Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases

Published on: September 29, 2014

Area of Science:

  • Biochemistry
  • Genetics
  • Neuroscience

Background:

  • Inherited muscular dystrophies are increasingly linked to defective glycosylation of alpha-dystroglycan.
  • These muscular dystrophies often present with central nervous system abnormalities.
  • Proper glycosylation of dystroglycan is essential for its ligand-binding function.

Purpose of the Study:

  • To highlight the significance of alpha-dystroglycan glycosylation errors in inherited muscular dystrophies.
  • To emphasize the role of O-mannosyl glycans in this pathway.
  • To underscore the need for identifying additional genes involved in dystroglycan glycosylation.

Main Methods:

  • Review of genetic and biochemical studies on inherited muscular dystrophies.
  • Analysis of known genes essential for dystroglycan glycosylation.
  • Examination of the O-mannosyl glycan pathway.

Main Results:

  • Six genes have been identified as critical for functional dystroglycan glycosylation.
  • These genes are primarily involved in O-mannosyl glycan formation.
  • Genetic heterogeneity suggests the involvement of other, yet unidentified, genes.

Conclusions:

  • Defects in dystroglycan glycosylation represent a significant cause of inherited muscular dystrophy.
  • Further identification of genes in the O-mannosyl glycan pathway is necessary.
  • Understanding this pathway is key to advancing research on muscular dystrophies and related neurological disorders.